Hydrate Inhibitors Market Report, by Inhibitor Type (Thermodynamic Inhibitors, Low Dosage Hydrate Inhibitors (LDHI’s), and Hybrid) - Size, Share, trends, and Forecast to 2025

  • Published On : Jul 2018 |
  • Pages : 125 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

­­­Global Hydrate Inhibitors Market - Insights

Hydrate inhibitors are chemical substances or devices that are designed to control the formation of hydrates during the process of natural gas production. Natural gas hydrates are ice-like solids that form when natural gas and free water are combined at low temperature and high pressure. It is formed at a gas or an oil condensate well.

Hydrate inhibitors aid in reducing hydrate plugs and line blockages, which occur due to hydrate formation. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible.

The market for hydrate inhibitors is expected to exhibit high growth in the near future, owing to increasing demand for natural gas & crude oil. Growth of hydrate inhibitors market is dependent on natural gas consumption as hydrate inhibitors are used to prevent or reduce gas hydrate formation in offshore and onshore production system. According to the International Energy Outlook 2017, U.S. Energy Information Administration, world energy consumption is estimated to increase from 575 quadrillion British thermal units (Btu) in 2015 to 663 quadrillion Btu by 2030. Furthermore, it is estimated to increase to 736 quadrillion Btu by 2040, thereby increasing demand for various energy sources including natural gas.

However, political instability and low prices of oil is a major factor negatively affecting growth of the global hydrate inhibitors market. According to Organization of the Petroleum Exporting Countries (OPEC), political instability has negative impacted oil and gas production in Venezuela in the Latin American region and it has witnessed a significant decrease. For instance, according to The U.S. Energy Information Administration (EIA), crude oil production in Venezuela was 2.3 million barrels per day (b/d) in 2016, which is decreased to 1.6 million b/d in January 2018.

The global hydrate inhibitor market was valued at US$ 170.0 Million in 2017 and is anticipated to register a CAGR of 6.9% in terms of revenue, over the forecast period (2017 – 2025) to reach US$ 290.3 million by 2025.

Figure 1. Global Hydrate Inhibitors Market Share, By Inhibitor Type, 2017

 Hydrate Inhibitors  | Coherent Market Insights

North America hydrate inhibitors market was valued at US$ 99.1 million in 2017. The U.S. held major market share in the North America hydrate inhibitors market. This is attributed to increasing exploration activities to discover untapped gas reserves and high consumption of natural gas in the country.

For instance, North America witnessed a shale boom post 2000, which has resulted in energy self-sufficiency. Also, superior technology has allowed North American shale producers to achieve breakeven at US$ 50 per barrel scenario. The availability of low cost feedstock has allowed petrochemical industry to thrive in the country. The major shale basins in the U.S. are Permian, Niobrara, Eagle Ford, Bakken, Marcellus, and Anadarko.

For instance, according to U.S. Energy Information Administration, total consumption of natural gas in the U.S. was 26,155 billion cubic feet in 2016, which increased to 27,090 billion cubic feet in 2017.

Hydrate inhibitors market is expected to grow rapidly in Asia Pacific during the forecast period (2018-2025). This is attributed to increasing demand for hydrate inhibitors from countries including China, Japan, South Korea, and India. Asia Pacific is heavily reliant on hydrocarbon imports from Middle East and Africa. According to the Energy Information Administration, India is host to large gas reserves off its east coast. Also, China's exploitable shale gas reserves are estimated at 21.8 trillion cubic meters, with proven reserves at 544.1 billion cubic meters.

In addition to this, increasing government initiatives for supporting new development and technology in hydrate inhibitor in offshore is also expected to aid in growth of the market. For instance, according to India Brand Equity Foundation (IBEF), Oil Industry Development Board (OIDB) has sanctioned US$ 37.04 million for the National Gas Hydrate Programme (NGHP) in 2016. These activities are shared between OIDB, ONGC, Oil India and Indian Oil Corporation for the development of hydrate inhibitors in offshore.

Figure 2. Global Hydrate Inhibitors Market Share (%), By Region, 2017

Hydrate Inhibitors  | Coherent Market Insights

Key players operating in the global hydrate inhibitors market include Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited.

Hydrate inhibitors are used to prevent or reduce gas hydrate formation. Gas hydrates are formed in offshore production systems under low temperature and high pressure conditions. These hydrates block pipelines, drill strings, BOP’s, by forming plugs, and cause flow assurance issues. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible options. However, political instability and low price of oil is a major factor negatively affecting growth of the global hydrate inhibitors market.

Market Dynamics

Increasing demand for natural gas and oil is expected to boost the global hydrate inhibitors market growth. Global demand for energy is increasing rapidly. Moreover, world natural gas consumption is expected to increase by 43% from 2015 to 2040 according to the International Energy Outlook 2017, as natural gas continues to be the fuel for electric power generation and for application in industrial sectors. Electric power and industrial sector uses around 75% of the natural gas of the projected increase in total consumption between 2015 and 2040.

By region, North America held a major market share of 58% in 2017. Middle East and Europe held significant market share in the global hydrate inhibitors market.

Europe is a lucrative market for hydrate inhibitors with significant demand due to high offshore oil production from the region in 2017 and it is expected to increase during forecast period. For instance, according to the EU, 567 million barrels of offshore oil had been produced in the U.K. in 2012. Furthermore, 95 million barrels of offshore oil and 105 million barrels of offshore gas production was recorded in Norway in 2012, according to the EU.

Key features of the study:

  • This report provides in-depth analysis of hydrate inhibitors market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2025), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global hydrate inhibitors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study includes Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global hydrate inhibitors market report caters to various stakeholders in this industry including investors, suppliers, hydrate inhibitors manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the hydrate inhibitors market

Detailed Segmentation:

  • Global Hydrate Inhibitors Market, By Inhibitor Type:
    • Thermodynamic Inhibitors
      • Methanol
      • Mono Ethylene Glycol (MEG)
    • Low Dosage Hydrate Inhibitors (LDHI’s)
      • Anti-Agglomeration Inhibitors/Surfactants
        • Quaternary Ammonium Compounds
        • Amides
        • Bio-surfactants
      • Kinetic Inhibitors
        • Polyvinylcaprolactam
        • Polyvinylpyrrolidone
        • Polyethyloxazoline
        • N-methyl-N-vinylacetamide
        • Tetra pentyl ammonium bromide
        • Butoxy-ethanol
      • Emulsifiers
    • Hybrid
  • Global Hydrate Inhibitors Market, By Geography:
    • North America
      • U.S.
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Canada
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
    • Europe
      • U.K.
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Germany
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • France
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Italy
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Spain
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Russia
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Rest of Europe
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
    • Asia Pacific
      • China
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • India
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Japan
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • ASEAN
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Australia
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • South Korea
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Rest of Asia Pacific
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
    • Latin America
      • Brazil
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Argentina
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Mexico
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Rest of Latin America
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
    • Middle East
      • GCC
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Israel
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Rest of Middle East
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
    • Africa
      • Northern Africa
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • Central Africa
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
      • South Africa
        • By Inhibitor Type:
          • Thermodynamic Inhibitors
            • Methanol
            • Mono Ethylene Glycol (MEG)
          • Low Dosage Hydrate Inhibitors (LDHI’s)
            • Anti-Agglomeration Inhibitors/Surfactants
              • Quaternary Ammonium Compounds
              • Amides
              • Bio-surfactants
            • Kinetic Inhibitors
              • Polyvinylcaprolactam
              • Polyvinylpyrrolidone
              • Polyethyloxazoline
              • N-methyl-N-vinylacetamide
              • Tetra pentyl ammonium bromide
              • Butoxy-ethanol
            • Emulsifiers
          • Hybrid
  • Company Profiles
    • Halliburton*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Ashland Global Specialty Chemicals Inc.
    • Ecolab Inc.
    • Baker Hughes Inc.
    • Innospec Inc.
    • JSC Gazprom Neftekhim Salavat
    • BASF SE
    • Evonik Industries AG
    • Clariant AG
    • GasHydrate LLC
    • Schlumberger Limited

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Inhibitor Type
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
      • Regulatory Scenario
      • Industry Trend
      • Merger and Acquisitions
      • New Product Approvals/Launch
      • Promotion and Marketing Initiatives
    • Cost Tier Down Analysis
  4. Global Hydrate Inhibitors Market, By Inhibitor Type, 2018- 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2018 - 2025
      • Segment Trends
    • Thermodynamic Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2025, (US$ Million)
    • Low Dosage Hydrate Inhibitors (LDHI’s)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2025, (US$ Million)
    • Hybrid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2025, (US$ Million)
  5. Global Hydrate Inhibitors Market, By Region, 2018- 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2025
    • North America
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Country, 2018 - 2025
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
    • Europe
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Country, 2018 - 2025
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Spain
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Country, 2018 - 2025
        • China
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
    • Latin America
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Country, 2018 - 2025
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Argentina
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
    • Middle East
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Country, 2018 - 2025
        • GCC
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
    • Africa
      • Market Share Analysis, By Country, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Country, 2018 - 2025
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
  6. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Halliburton
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Ashland Global Specialty Chemicals Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Ecolab Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Baker Hughes Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Innospec Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • JSC Gazprom Neftekhim Salavat
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • BASF SE
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Evonik Industries Ag
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Clariant AG
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • GasHydrate LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Schlumberger Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

* Browse 150 market data tables* and 90 figures* on "Hydrate Inhibitors Market” - Global forecast to 2025.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.